Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congraulations to Professor Ming Lei who has been announced as the recipient of the 2026 Mabel Fitzgerald Prize for Diversity in Physiology, presented by the Physiological Society.

Professor Ming Lei2026 Prize Lecture recipients will be featured at events throughout the Physiological Society’s 150th anniversary celebrations. The Mabel Fitzgerald Prize celebrates excellence in physiological research from scientists from underrepresented backgrounds. Ming’s research has transformed cardiacscience by uncovering new pacemaking mechanisms and therapeutic targets, and leading a global overhaul of antiarrhythmic drug classification. Ming commented, “I am so delighted by this remarkable recognition at occasion of the Physiological Society’s 150 anniversary”, while Fran said “Very many congratulations to Ming on this amazing achievement”.

Similar stories

EMA approval of IntraBio’s Aqneursa marks a major milestone for the Department of Pharmacology, with further Phase 3 success in Ataxia Telangiectasia

On 21 January, the European Medicines Agency (EMA) approved Aqneursa, a new treatment for Niemann-Pick Disease Type C (NPC) in adults and children, marking a major milestone for research originating in the Department of Pharmacology. Aqneursa already received US FDA approval (September 2024), enabling patient access on both sides of the Atlantic.